New approaches to specific immunomodulation in transplantation (Q41091885)

26 September 2017

1 reference

title

New approaches to specific immunomodulation in transplantation (English)

1 reference

26 September 2017

Colovai AI

1

1 reference

26 September 2017

Molajoni ER

series ordinal

2

1 reference

26 September 2017

Cortesini R

series ordinal

3

1 reference

26 September 2017

Suciu-Foca N

series ordinal

4

1 reference

26 September 2017

publication date

1 January 1996

1 reference

International Reviews of Immunology

26 September 2017

published in

1 reference

26 September 2017

volume

13

1 reference

26 September 2017

issue

3

1 reference

26 September 2017

page(s)

161-172

1 reference

The molecular basis of alloreactivity

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Indirect presentation of MHC antigens in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Processed MHC class I alloantigen as the stimulus for CD4+ T-cell dependent antibody-mediated graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

T cell recognition of self-human histocompatibility leukocyte antigens (HLA)-DR peptides in context of syngeneic HLA-DR molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Indirect T cell allorecognition: a cyclosporin A resistant pathway for T cell help for antibody production to donor MHC antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

The biochemistry and cell biology of antigen processing and presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Mechanisms influencing the immunodominance of T cell determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Antigen-processing organelles from DRB1*1101 and DRB1*1104 B cell lines display a differential degradation activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

T cell determinant structure: cores and determinant envelopes in three mouse major histocompatibility complex haplotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Dominance and crypticity of T cell antigenic determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Allelic variation in the DR subregion of the human major histocompatibility complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Preferential pairing of T-B specificities in the same antigen: the concept of directional help

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Predominant use of a V alpha gene segment in mouse T-cell receptors for cytochrome c.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brains of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Contribution of direct and indirect recognition pathways to T cell alloreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Exogenous peptides compete for the presentation of endogenous antigens to major histocompatibility complex class II-restricted T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

T cell receptor antagonists and partial agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Antigen analogs/MHC complexes as specific T cell receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Disease inhibition by major histocompatibility complex binding peptide analogues of disease-associated epitopes: more than blocking alone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Identifying strategies for immune intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Dominance of one T-cell receptor in the H–2Kb/TNP response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189609061745

10.3109/08830189609061745

21 January 2018

Identifiers

DOI

1 reference

26 September 2017

1 reference